Status of scintimammography and its relationship to other detection methods for breast cancer

被引:4
作者
Kakuda, JT
Stuntz, ME
Vargas, HI
Khalkhali, I
机构
[1] Univ Calif Los Angeles, Harbor Med Ctr, Dept Surg, Torrance, CA 90509 USA
[2] Univ Calif Los Angeles, Harbor Med Ctr, Dept Radiol, Torrance, CA 90509 USA
关键词
D O I
10.1089/cbr.1999.14.435
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the most important malignancy for women of the world's industrialized nations. It is second only to lung cancer in cancer-related mortality(1) Early detection is the best means of improving survival; the cornerstone of early diagnosis is mammography. Given the endemic nature of breast cancer, screening mammography has secured a routine place in health maintenancefor women, although it is less than perfect To aid in the diagnosis of malignant breast disease, other imaging modalities have involved: ultrasound, magnetic resonance imaging (MRI), positron emission tomography (PET), and SMM. Scintimammography (SMM) is rapidly evolving with a variety of applications for the management of breast disease. This technology has become a complementary modality to other conventional methods of breast imaging. This review will focus on the science behind SMM and how it is currently used in the management of breast lesions.
引用
收藏
页码:435 / 442
页数:8
相关论文
共 58 条
[1]  
*ACS, 1998, CANC FACTS FIG 1998
[2]  
*AM COLL RAD, 1998, MAMM DAT BAS SYST BI
[3]   MAMMOGRAPHIC SCREENING AND MORTALITY FROM BREAST-CANCER - THE MALMO MAMMOGRAPHIC SCREENING TRIAL [J].
ANDERSSON, I ;
ASPERGREN, K ;
JANZON, L ;
LANDBERG, T ;
LINDHOLM, K ;
LINELL, F ;
LJUNGBERG, O ;
RANSTAM, J ;
SIGFUSSON, B .
BRITISH MEDICAL JOURNAL, 1988, 297 (6654) :943-948
[4]  
BARDFELD PA, 1994, P ARS, P300
[5]  
BASSETT LW, 1991, AJR, V145, P449
[6]   AXILLARY LYMPH-NODE METASTASES IN BREAST-CANCER - PREOPERATIVE DETECTION WITH US [J].
BRUNETON, JN ;
CARAMELLA, E ;
HERY, M ;
AUBANEL, D ;
MANZINO, JJ ;
PICARD, JL .
RADIOLOGY, 1986, 158 (02) :325-326
[7]  
BUTLER JA, 1990, ARCH SURG-CHICAGO, V125, P893
[8]  
CAPLAN L, 1997, AJR, V168, pP24
[9]  
CARVALHO PA, 1992, J NUCL MED, V33, P1516
[10]   Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer [J].
Ciarmiello, A ;
Del Vecchio, S ;
Silvestro, P ;
Potena, MI ;
Carriero, MV ;
Thomas, R ;
Botti, G ;
D'Aiuto, G ;
Salvatore, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1677-1683